- Home
- MNY vs TPST Comparison
MNY vs TPST Comparison
Compare MNY & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- TPST
- Stock Information
- Founded
- MNY 2014
- TPST 2011
- Country
- MNY Singapore
- TPST United States
- Employees
- MNY N/A
- TPST N/A
- Industry
- MNY
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- TPST Health Care
- Exchange
- MNY Nasdaq
- TPST Nasdaq
- Market Cap
- MNY 31.9M
- TPST 33.0M
- IPO Year
- MNY N/A
- TPST N/A
- Fundamental
- Price
- MNY $1.62
- TPST $6.67
- Analyst Decision
- MNY Strong Buy
- TPST Hold
- Analyst Count
- MNY 1
- TPST 3
- Target Price
- MNY $4.00
- TPST $30.00
- AVG Volume (30 Days)
- MNY 436.8K
- TPST 73.0K
- Earning Date
- MNY 06-13-2025
- TPST 08-07-2025
- Dividend Yield
- MNY N/A
- TPST N/A
- EPS Growth
- MNY N/A
- TPST N/A
- EPS
- MNY N/A
- TPST N/A
- Revenue
- MNY $71,649,746.00
- TPST N/A
- Revenue This Year
- MNY $16.97
- TPST N/A
- Revenue Next Year
- MNY $19.35
- TPST N/A
- P/E Ratio
- MNY N/A
- TPST N/A
- Revenue Growth
- MNY N/A
- TPST N/A
- 52 Week Low
- MNY $0.55
- TPST $5.35
- 52 Week High
- MNY $1.85
- TPST $29.38
- Technical
- Relative Strength Index (RSI)
- MNY 85.82
- TPST 42.53
- Support Level
- MNY $0.99
- TPST $7.06
- Resistance Level
- MNY $1.10
- TPST $7.05
- Average True Range (ATR)
- MNY 0.14
- TPST 0.26
- MACD
- MNY 0.06
- TPST -0.05
- Stochastic Oscillator
- MNY 92.75
- TPST 9.39
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.